![Kamil Erozkan: Thrilled to present our study on TNT in early-stage rectal cancer at DDW 2024](https://oncodaily.com/pub/uploads/2024/05/fe039de2442446dbb9878e56ec87b33f-e1716126296831.jpg)
Photo from Kamil Erozkan/X
May 22, 2024, 07:46
Kamil Erozkan: Thrilled to present our study on TNT in early-stage rectal cancer at DDW 2024
Kamil Erozkan, Research Fellow at Cleveland Clinic, shared a post on X:
“Thrilled to present our study on TNT in early-stage rectal cancer at DDW 2024 (Digestive Disease Week).
- It was remarkable to achieve a 100% complete response rate.
- Reduced-dose TNT might be considered for future treatment plans.
Honored to work under the mentorship of Emre Gorgun.”
Source: Kamil Erozkan/X